Loading news...
Core Scientific Inc. (NASDAQ: CORZ) has signaled a definitive reversal in market sentiment this week, as its momentum score underwent a massive week-on-week transformation, jumping from 78.59 to a bullish 87.83.
Core Scientific (CORZ) momentum hits 87.83 as KBW raises PT to $25, citing a successful pivot from Bitcoin mining to AI infrastructure.
Universal Beteiligungs und Servicegesellschaft mbH grew its position in Core Scientific, Inc. (NASDAQ: CORZ) by 39.9% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 452,806 shares of the company's stock after buying an additional 129,133 shares during
Core Scientific, Inc. (NASDAQ: CORZ - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twenty-two brokerages that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, five have given a hold rating, fourteen have issued a buy rating and one has
Sifting the World's Chris DeMuth Jr. shares his strategy for focusing on mispricings, hidden value, and opportunities in overlooked or misunderstood situations. WLFC's asset value is underappreciated; partnerships could monetize up to $800M of its $1B market cap, clarifying true inventory worth.
Core Scientific Inc. (NASDAQ: CORZ) has signaled a definitive reversal in market sentiment this week, flashing bullish technical signals following an upgrade from BTIG.
Core Scientific (CORZ) is getting fresh love from Wall Street after BTIG upgraded the stock to Buy, arguing that walking away from its CoreWeave (CRWV)merger ma
San Francisco-based Valiant Capital Management increased its position in Core Scientific by 1.68 million shares in the third quarter. The move contributed to a net value change of $34.34 million.
Core Scientific, Inc. (NASDAQ: CORZZ - Get Free Report)'s stock price was down 1.7% during mid-day trading on Monday. The company traded as low as $14.82 and last traded at $14.9550. Approximately 4,615 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 43,753 shares. The stock had previously
Zurich-based PSquared Asset Management initiated a 405,800-share stake in Core Scientific during the third quarter. The position was worth about $7.28 million as of September 30.
Connective Portfolio Management LLC purchased a new stake in Core Scientific, Inc. (NASDAQ: CORZ) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 35,000 shares of the company's stock, valued at approximately $607,000. Several other large investors have also recently modified
New York City-based DSC Meridian Capital added nearly 1.4 million shares of Core Scientific in the third quarter. The net position change from the previous period was about $25.4 million.
Core Scientific is undergoing a strategic pivot from BTC mining to AI and HPC infrastructure, targeting higher-margin colocation revenue. The terminated CoreWeave acquisition leaves CORZ with a lucrative 12-year, $10B+ contract, providing high revenue visibility and strong margins. Despite high customer concentration and legacy digital asset exposure, I am bullish on CORZ given its aggressive growth ambitions and undervalued status.
Stock News Fed set for a âhawkish cutâ: The Federal Reserve is widely expected to deliver a third 25 bp rate cut amid sharp divisions over inflation vs. job
Core Scientific's transition from Bitcoin mining to High Performance Computing has been extremely strategic, allowing them to capitalize on the AI-driven data center boom. Its Colocation Services now deliver higher gross margins of 26% compared to its mining operations and are expected to reach up to ~80% on new CRWV contracts. CORZ-CRWV's partnership notably reduces CORZ's capital/balance sheet burden and secures its AI growth opportunities over the next decade.
New York City-based Kintayl Capital bought 570,054 shares of Core Scientific worth an estimated $10.2 million during the third quarter. The position accounts for 6.3% of Kintayl's 13F-reportable assets.
Core Scientific is reinventing itself-fast-and one major investor just made a bold bet on where that pivot leads.
Aurelius Capital Management LP trimmed its holdings in shares of Core Scientific, Inc. (NASDAQ: CORZ) by 35.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 438,394 shares of the company's stock after selling 236,058 shares during
Shares of Core Scientific, Inc. (NASDAQ: CORZ - Get Free Report) have been assigned a consensus recommendation of "Hold" from the twenty-three ratings firms that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have assigned a buy rating and
Shares of CoreWeave, Inc. (NASDAQ: CRWV) and Core Scientific, Inc. (NASDAQ: CORZ) climbed in after-hours trading Wednesday after NVIDIA Corp.'s (NASDAQ: NVDA) blockbuster third quarter earnings report set off a "pick-and-shovel" rally.